Medicare Enrolled
Dr. Sarath Reddy, MD
Cardiovascular Disease · Brooklyn, NY
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reddy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reddy
Dr. Sarath Reddy is a cardiovascular disease specialist in Brooklyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Reddy performed 2,136 Medicare services across 1,446 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reddy received a total of $5,641 from 25 pharmaceutical and/or device companies across 197 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reddy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 44% volume in NY
$5,641 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,136
Medicare services
Top 44% in NY for cardiovascular disease
1,446
Unique beneficiaries
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~107 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
408 | $71 | $170 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
221 | $173 | $323 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
196 | $95 | $255 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
195 | $77 | $212 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
186 | $12 | $35 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
140 | $110 | $320 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
117 | $58 | $170 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
98 | $409 | $1,131 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
96 | $58 | $400 |
| Adenosine injection, 1 mg Administration of a 1 mg dose of adenosine medication. This code is specifically for adenosine and excludes adenosine phosphate compounds. |
88 | $0 | $20 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
87 | $23 | $150 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
58 | $42 | $580 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
57 | $21 | $200 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
35 | $27 | $200 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
35 | $21 | $60 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
31 | $182 | $490 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $118 | $295 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
26 | $228 | $635 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
23 | $31 | $150 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
11 | $184 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
15.7% high complexity
30.9% medium
53.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,641
Total received (2018-2024)
Avg $806/year across 7 years
Top 29% in NY for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
197
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,542 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$99 (1.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,431
2023
$1,151
2022
$681
2021
$909
2020
$472
2019
$348
2018
$649
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$578
Novartis Pharmaceuticals Corporation
$407
ZOLL Respicardia, Inc.
$141
AstraZeneca Pharmaceuticals LP
$107
Kestra Medical Technology Services, Inc.
$53
Amgen Inc.
$48
Boston Scientific Corporation
$32
Alnylam Pharmaceuticals Inc.
$29
CARDIVA MEDICAL, INC.
$24
Micro-tech Endoscopy USA, Inc.
$12
Top 3 companies account for 78.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,041
Medtronic, Inc.
$902
Novartis Pharmaceuticals Corporation
$887
Janssen Pharmaceuticals, Inc
$639
Boston Scientific Corporation
$322
Boehringer Ingelheim Pharmaceuticals, Inc.
$261
Merck Sharp & Dohme LLC
$250
Abbott Laboratories
$172
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$170
ZOLL Respicardia, Inc.
$141
Astellas Pharma US Inc
$117
Alnylam Pharmaceuticals Inc.
$112
Medtronic Vascular, Inc.
$106
CARDIVA MEDICAL, INC.
$100
Amgen Inc.
$93
SANOFI-AVENTIS U.S. LLC
$76
E.R. Squibb & Sons, L.L.C.
$54
Kestra Medical Technology Services, Inc.
$53
Novo Nordisk Inc
$36
Daiichi Sankyo Inc.
$21
PFIZER INC.
$20
AngioDynamics, Inc.
$20
Kiniksa Pharmaceuticals, Ltd.
$18
GE HEALTHCARE
$17
Micro-tech Endoscopy USA, Inc.
$12
Top 3 companies account for 50.2% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · Arcalyst · Arctic Front · Assure WCD · BRILINTA · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE 5F VCS · CARDIVA VASCADE 6/7F VCS · CardioMEMS HF System · Cardiva VASCADE 6/7F VCS · ELIQUIS · ENTRESTO · FARXIGA · General - EP · IN.PACT Admiral · INJECTAFER · INVOKANA · JARDIANCE · LEQVIO · LEXISCAN · LINQ II · LOKELMA · LifeVest · Lockado · MULTAQ · MYCARELINK · ONPATTRO · ONYX FRONTIER · Ozempic · PCI Optimization · PRALUENT · Repatha · SYMPLICITY G3 · VERQUVO · Vascular Closure Device · WATCHMAN FLX · XARELTO · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
1,825
Per 100K population
69.0
County median income
$78,548
Nearest hospital
BROOKLYN HOSPITAL CENTER - DOWNTOWN CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Reddy is a cardiac imaging specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Reddy experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Reddy performed 408 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reddy receive payments from pharmaceutical companies?
Yes. Dr. Reddy received a total of $5,641 from 25 companies across 197 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reddy's costs compare to other cardiologists in Brooklyn?
Dr. Reddy's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Brooklyn
Browse cardiologists in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NY
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NY
Which NY cardiologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology